AGILE THERAPEUTICS INC Quarterly Debt-to-equity in % from Q3 2020 to Q2 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Agile Therapeutics Inc quarterly Debt-to-equity history and growth rate from Q3 2020 to Q2 2024.
Agile Therapeutics Inc Debt-to-equity for the quarter ending June 30, 2024 was -180 %, a 39.2% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	-180	+116	+39.2%	Jun 30, 2024
Q1 2024	-191	+416	+68.6%	Mar 31, 2024
Q4 2023	-194	+726	+78.9%	Dec 31, 2023
Q3 2023	-230	+5.58K	+96%	Sep 30, 2023
Q2 2023	-296	-1.39K	-127%	Jun 30, 2023
Q1 2023	-607	-972	-266%	Mar 31, 2023
Q4 2022	-920	-1.07K	-702%	Dec 31, 2022
Q3 2022	-5.81K	-5.9K	-6932%	Sep 30, 2022
Q2 2022	1.09K	+1.03K	+1826%	Jun 30, 2022
Q1 2022	366	+325	+803%	Mar 31, 2022
Q4 2021	153	+122	+401%	Dec 31, 2021
Q3 2021	85.1	+61.2	+256%	Sep 30, 2021
Q2 2021	56.6			Jun 30, 2021
Q1 2021	40.5			Mar 31, 2021
Q4 2020	30.5			Dec 31, 2020
Q3 2020	23.9			Sep 30, 2020

* An asterisk sign (*) next to the value indicates that the value is likely invalid.